These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 19347882)
1. L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas. Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M J Surg Oncol; 2009 Jun; 99(7):433-8. PubMed ID: 19347882 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Nakajima T; Mori M Lung Cancer; 2009 Oct; 66(1):120-6. PubMed ID: 19171406 [TBL] [Abstract][Full Text] [Related]
3. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724 [TBL] [Abstract][Full Text] [Related]
4. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099 [TBL] [Abstract][Full Text] [Related]
5. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors. Kim DJ; Yang WI; Kim SH; Park IK; Chung KY Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946 [TBL] [Abstract][Full Text] [Related]
6. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294 [TBL] [Abstract][Full Text] [Related]
7. Proliferative activity and apoptosis in thymic epithelial neoplasms. Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014 [TBL] [Abstract][Full Text] [Related]
8. Steroid receptor expression in thymomas and thymic carcinomas. Mimae T; Tsuta K; Takahashi F; Yoshida A; Kondo T; Murakami Y; Okada M; Takeuchi M; Asamura H; Tsuda H Cancer; 2011 Oct; 117(19):4396-405. PubMed ID: 21437890 [TBL] [Abstract][Full Text] [Related]
9. Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence. Kaira K; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Oriuchi N; Kanai Y; Endo M; Kondo H; Nakajima T; Yamamoto N Anticancer Res; 2011 Nov; 31(11):3775-82. PubMed ID: 22110199 [TBL] [Abstract][Full Text] [Related]
10. Expression of proteasome subunit β5t in thymic epithelial tumors. Yamada Y; Tomaru U; Ishizu A; Kiuchi T; Marukawa K; Matsuno Y; Kasahara M Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487 [TBL] [Abstract][Full Text] [Related]
11. High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. Yanagisawa N; Ichinoe M; Mikami T; Nakada N; Hana K; Koizumi W; Endou H; Okayasu I J Clin Pathol; 2012 Nov; 65(11):1019-23. PubMed ID: 22813728 [TBL] [Abstract][Full Text] [Related]
12. L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Sakata T; Ferdous G; Tsuruta T; Satoh T; Baba S; Muto T; Ueno A; Kanai Y; Endou H; Okayasu I Pathol Int; 2009 Jan; 59(1):7-18. PubMed ID: 19121087 [TBL] [Abstract][Full Text] [Related]
13. Mutational status of EGFR and KIT in thymoma and thymic carcinoma. Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188 [TBL] [Abstract][Full Text] [Related]
14. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors. Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma. Dorfman DM; Shahsafaei A; Miyauchi A Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors. Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177 [TBL] [Abstract][Full Text] [Related]
17. LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells. Hayashi K; Jutabha P; Maeda S; Supak Y; Ouchi M; Endou H; Fujita T; Chida M; Anzai N J Pharmacol Sci; 2016 Nov; 132(3):201-204. PubMed ID: 27567475 [TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes. Kondo K; Mukai K; Sato Y; Matsuno Y; Shimosato Y; Monden Y Am J Surg Pathol; 1990 Dec; 14(12):1139-47. PubMed ID: 2252104 [TBL] [Abstract][Full Text] [Related]